STORAGE MANAGEMENT OF CLINICAL RESEARCH SUPPLIES OF A PHASE IIB/III, NATIONAL, MULTI-CENTRE, DOUBLE-BLIND AND RANDOMIZED STUDY

被引:0
|
作者
Harada, Lila M. [1 ]
Rodrigues, Enio Fernandes [1 ]
Ferreira, William de Paula [1 ]
da Silva, Adriano Manicoba [1 ]
Kawamoto Junior, Luiz Teruo [1 ]
机构
[1] Fed Inst Educ Sci & Technol Sao Paulo IFSP, Suzano, SP, Brazil
关键词
Clinical Trial; Supply; Storage; Good practices;
D O I
10.14488/BJOPM.2016.v13.n4.a3
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
New drugs suffer a long and slow proceeding to reach the market. On the one hand there are difficulties from the regulatory agency that delays the onset of clinical trial studies, on the other hand there is a slow patient recruitment during the course of the trial that prevents its completion. An efficient management of clinical trial supplies throughout the supply chain is essential. Thus, the objective of this study was to characterize the clinical supplies storage management in a national, multi-centre, double-blind and randomized study to evaluate the efficiency and safety of a combination of drugs to treat acute pain. The study was primarily focused on storage conditions of clinical supplies, detailing their distribution to the research sites. According to the data observed in this study, the clinical supplies storage management was not determinant for the slow patient recruitment process that reflected the delay to the end of the study. And although the centers were located in different states, there were no delays, loss or damage during storage and distribution that could compromise the proper stock and storage management of clinical trial supplies.
引用
收藏
页码:430 / 441
页数:12
相关论文
共 50 条
  • [21] Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
    G Horneff
    S Fitter
    HI Huppertz
    I Foeldvari
    K Kuemmerle-Deschner
    R Kuester
    N Tzaribacev
    A Thon
    M Borte
    G Ganser
    R Trauzeddel
    K Minden
    Pediatric Rheumatology, 9 (Suppl 1)
  • [22] ETHICS OF RANDOMIZED DOUBLE-BLIND CLINICAL RESEARCH PROTOCOLS
    AVENDANO, JMU
    REVISTA MEDICA DE CHILE, 1987, 115 (09) : 897 - 901
  • [23] Tocilizumab in Myositis: Results of a Phase IIb Double-Blind Randomized Controlled Trial
    Aggarwal, Rohit
    Rockette, Howard
    Venturupalli, Swamy
    Marder, Galina
    Dimachkie, Mazen
    Gazeley, David
    Ernste, Floranne C.
    Crofford, Leslie
    Moghadam-Kia, Siamak
    Koontz, Diane
    Zhu, Lei
    Oddis, Chester
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
    Aisen, Paul S.
    Gauthier, Serge
    Ferris, Steven H.
    Saumier, Daniel
    Haine, Denis
    Garceau, Denis
    Anh Duong
    Suhy, Joyce
    Oh, Joonmi
    Lau, Wan C.
    Sampalis, John
    ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (01) : 102 - 111
  • [25] A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis
    Pasero, G
    Marcolongo, R
    Serni, U
    Parnham, MJ
    Ferrer, F
    CURRENT MEDICAL RESEARCH AND OPINION, 1995, 13 (06) : 305 - 315
  • [26] Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study
    Liu, Lunfei
    Chen, Jisu
    Xu, Jinhua
    Yang, Qinping
    Gu, Chaoying
    Ni, Chunya
    Li, Linfeng
    Lu, Xueyan
    Yao, Zhirong
    Tao, Jianfeng
    Guo, Yifeng
    Fang, Hong
    Ding, Yingguo
    Qiang, Qihong
    Zhou, Naihui
    Wang, Miaomiao
    Deng, Danqi
    Xie, Hong
    Li, Shenqiu
    Huang, Yongchu
    Zhao, Naiqing
    Zheng, Min
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 3540 - 3547
  • [27] Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial
    Russo, Rossana Sanchez
    Gasperini, Serena
    Bubb, Gillian
    Neuman, Linda
    Sloan, Leslie S.
    Diaz, George A.
    Enns, Gregory M.
    ECLINICALMEDICINE, 2024, 68
  • [28] Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT
    Currow, David
    Louw, Sandra
    Mccloud, Philip
    Fazekas, Belinda
    Plummer, John
    Mcdonald, Christine
    Agar, Meera
    Clark, Katherine
    Mccaffrey, Nikki
    Abernethy, Amy
    Ekstrom, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind PlaceboControlled Randomized Phase IIb Trial
    Sampson, Hugh A.
    Agbotounou, Wence
    Thebault, Claude
    Charles, Ruban
    Martin, Laurent
    Yang, William H.
    Sussman, Gordon L.
    Brown-Whitehorn, Terri F.
    Nadeau, Kari C.
    Cheema, Amarjit Singh
    Leonard, Stephanie A.
    Pongracic, Jacqueline A.
    Sauvage, Christine
    Assa'ad, Amal H.
    de Blay, Frederic
    Bird, J. Andrew
    Tilles, Stephen A.
    Boralevi, Franck
    Bourrier, Thierry
    Shreffler, Wayne G.
    Hebert, Jacques
    Green, Todd David
    van Wijk, Roy Gerth
    Knulst, Andre C.
    Kanny, Gisele
    Kowalski, Marek L.
    Schneider, Lynda C.
    Benhamou, Pierre Henri
    Dupont, Christophe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB390 - AB390